Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chloride opsins are a class of light-sensitive proteins used in optogenetics to modulate cellular membrane potential by transporting chloride ions. In the context of glioblastoma research, these opsins are expressed in glioma cells via gene therapy vectors. Upon activation by specific wavelengths of light, the opsins pump chloride into the cells, which has been shown to reduce tumor proliferation and invasion while also modulating the hyperexcitability of surrounding neurons. This approach targets the dysregulated chloride homeostasis observed in the glioblastoma microenvironment, specifically addressing the upregulation of chloride transporters like NKCC1 and ClC-3 in tumor cells and associated neurons.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chloride opsin.